X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3013) 3013
Book Chapter (26) 26
Newsletter (13) 13
Newspaper Article (13) 13
Conference Proceeding (2) 2
Magazine Article (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2106) 2106
active crohns-disease (1135) 1135
gastroenterology & hepatology (1131) 1131
inflammatory bowel disease (832) 832
crohn's disease (735) 735
active ulcerative-colitis (717) 717
crohns-disease (716) 716
ulcerative colitis (713) 713
animals (681) 681
male (643) 643
double-blind (640) 640
female (622) 622
ulcerative-colitis (533) 533
inflammatory-bowel-disease (505) 505
adult (462) 462
pharmacology & pharmacy (421) 421
placebo-controlled trial (417) 417
immunology (408) 408
inflammatory bowel diseases (388) 388
inflammatory bowel diseases - drug therapy (371) 371
middle aged (370) 370
treatment outcome (335) 335
inflammation (308) 308
infliximab (298) 298
therapy (262) 262
necrosis-factor-alpha (257) 257
mice (246) 246
inflammatory bowel diseases - immunology (242) 242
cytokines (230) 230
care and treatment (229) 229
health aspects (222) 222
tumor necrosis factor-alpha - antagonists & inhibitors (221) 221
research (219) 219
crohn disease - drug therapy (213) 213
inflammatory bowel diseases - therapy (213) 213
aged (211) 211
tumor-necrosis-factor (209) 209
antibodies, monoclonal - therapeutic use (207) 207
maintenance therapy (205) 205
rheumatoid-arthritis (201) 201
colitis, ulcerative - drug therapy (197) 197
analysis (192) 192
intestine (191) 191
medicine, general & internal (190) 190
risk factors (189) 189
adolescent (186) 186
crohn’s disease (186) 186
immunosuppressive agents - therapeutic use (183) 183
review (178) 178
colitis (168) 168
active rheumatoid-arthritis (167) 167
abridged index medicus (164) 164
monoclonal-antibody (162) 162
rheumatology (161) 161
remission (157) 157
randomized controlled-trial (156) 156
anti-inflammatory agents - therapeutic use (155) 155
gastrointestinal diseases (150) 150
medicine & public health (150) 150
drug therapy (145) 145
patients (144) 144
gastroenterology (141) 141
diagnosis (140) 140
medicine, research & experimental (140) 140
disease (137) 137
disease models, animal (136) 136
efficacy (131) 131
colon (130) 130
child (129) 129
expression (128) 128
microbiota (128) 128
pathogenesis (124) 124
5-aminosalicylic acid (123) 123
inflammatory bowel diseases - pathology (123) 123
young adult (123) 123
chronic active hepatitis (122) 122
oncology (122) 122
enteral nutrition (121) 121
medical research (121) 121
cell biology (120) 120
clinical trials (120) 120
intestinal mucosa - pathology (119) 119
gastroenterology and hepatology (117) 117
digestive system diseases (116) 116
medicine (114) 114
crohn disease - immunology (113) 113
gastrointestinal agents - therapeutic use (113) 113
rheumatoid arthritis (113) 113
inflammatory bowel diseases - metabolism (112) 112
physiological aspects (112) 112
regulatory t-cells (111) 111
t-cells (111) 111
t cells (110) 110
clinical trials as topic (109) 109
crohn disease - therapy (109) 109
intestinal mucosa - metabolism (108) 108
nf-kappa-b (107) 107
nutrition & dietetics (107) 107
intestinal inflammation (106) 106
active ankylosing-spondylitis (105) 105
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2992) 2992
German (51) 51
French (21) 21
Spanish (20) 20
Polish (9) 9
Japanese (7) 7
Portuguese (4) 4
Croatian (1) 1
Korean (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gut, ISSN 0017-5749, 05/2011, Volume 60, Issue 5, pp. 571 - 607
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10080, pp. 1699 - 1709
Summary Background The interleukin-23 pathway is implicated genetically and biologically in the pathogenesis of Crohn's disease... 
Internal Medicine | TRIAL | CELLS | MEDICINE, GENERAL & INTERNAL | ANTI-TNF | INFLAMMATORY-BOWEL-DISEASE | EFFICACY | ULCERATIVE-COLITIS | NECROSIS-FACTOR ANTAGONISTS | ANTITUMOR | MAINTENANCE THERAPY | FACTOR-ALPHA | Severity of Illness Index | Interleukin-23 Subunit p19 - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Remission Induction | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal - administration & dosage | Crohn Disease - drug therapy | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Medical research | Interleukins | Intravenous administration | Pathogenesis | Mucosa | Interleukin | Interleukin 23 | Antagonists | Evidence-based medicine | Intravenous therapy | Randomization | Endoscopes | Motivation | Gastroenterology | Remission | Tumor necrosis factor-TNF | Colon | Safety | Active control | Chronic illnesses | Psoriasis | Cytokines | Ileitis | Nausea | Inflammation | Crohn's disease | Disease control | Patients | Ileum | Crohns disease | Inflammatory bowel disease | Interactive systems | Tumor necrosis factor | Ulcers | TNF inhibitors | Tumors
Journal Article
Journal Article
Journal of gastroenterology, ISSN 1435-5922, 2018, Volume 53, Issue 3, pp. 305 - 353
Journal Article